The initial phase of GENIE, which stands for Genomics, Evidence, Neoplasia, Information, Exchange, involves seven founding members and two informatics partners.
The Personalized Reproductive Medicine Initiative will investigate how an individual's genetic signature and personalized metrics affect overall fertility.
The consortium, a group formed by a number of participants in Oxford Nanopore's MinIon early-access program (MAP), plans to conduct a series of projects.
The database of genotype, phenotype, and clinical data from multi-drug resistant TB cases may support improved diagnostic development and clinical decision making.
Illumina is the latest to join the consortium, which is focused on personalizing cancer care.
The effort brings together gene banks, researchers, plant breeders, and big data experts, all of whom will use genomics to unlock crop diversity.
The gene fusion assay maker is the sixth member to join the consortium, which also includes Illumina and several pharmaceutical companies.
The oncology data warehouse started by the Moffitt Cancer Center and Ohio State University Comprehensive Cancer Center now has nine members.
DNAnexus' platform will support data analysis and sharing for the third phase of the Encyclopedia of DNA Elements project.
The alliance is developing new optical DNA mapping technologies for diagnostic applications.
The nonprofit Biden Cancer Initiative is suspending its operations, according to the Associated Press.
Researchers examine how white nationalists handle personal genetic ancestry results that conflict with their racist worldview, the New York Times reports.
NPR speaks with research participants before and after they learn their APOE E4 status, which affects their risk of developing Alzheimer's disease.
In PLOS this week: genetic characterization of Toxoplasma gondii strains, Crimean-Congo Hemorrhagic Fever Virus uncovered in Sudan, and more.